Interferon signaling patterns in peripheral blood lymphocytes may predict clinical outcome after high-dose interferon therapy in melanoma patients

BACKGROUND: High-dose Interferon (HDI) therapy produces a clinical response and achieves relapse-free survival in 20-33% of patients with operable high risk or metastatic melanoma. However, patients may develop significant side effects frequently necessitating dose reduction or discontinuation of th...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Simons, Diana L, Lee, Gerald, Kirkwood, John M, Lee, Peter P
Format: Artigo
Langue:Inglês
Publié: BioMed Central 2011
Sujets:
Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3114759/
https://ncbi.nlm.nih.gov/pubmed/21545749
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1479-5876-9-52
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires